Running head: TEAM-BASED CARE IN THE MANAGEMENT OF 17   Appendix A Synthesis Table Year Design Level of Evidence Study Length Arevian Coleman Cramm 2005 SR (Q) V 2009 SR I 2014 SR I 3.5 yrs 9 yr span 2 yrs 82 981 18 Author Cramm Findley Glynn #2 Study Characteristics 2014 2014 2011 SR Desc SR I VI I 2 yrs 1 yr Population Demographics Harris Katon Litaker Shortell 2011 RCT II 2010 RCT II 2003 RCT II 2004 CS (C) IV 2 yrs 1 yr 1 yr - 1749 60 214 14 157 1 40 X X X X X X Sample Size N n Team Care Basis in CCM Evaluation of CDM 375 1 X X X X X X X 106 22 3309 10 Independent Variables X X X X X X X X X Dependent Variables Practice Centered Effects Team ↑ Satisfaction Documentation ↑ Sustainability Expansion Patient ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ - improved, ↓ - decreased, ↔ - limited effects, BP – blood pressure, CCM – Chronic Care Model, CS (C) – cross-sectional (cohort), CVD events – cardiovascular disease related events, DBP – diastolic blood pressure, Desc – Descriptive, HbA1c – glycosylated hemoglobin level, HDL – high density lipoprotein cholesterol level, LDL – low density lipoprotein cholesterol level, LOE – level of evidence, N – sample size (people), n – sample size (studies/programs), QOC – quality of care, QOL – quality of life, RCT – Randomized Control Trial, SBP – systolic blood pressure, SR – Systematic Review, SR (Q) – Systematic Review (Qualitative study design)   TEAM-BASED CARE IN THE MANAGEMENT OF TYPE 2 DIABET Recruitment Yearly ↑ Screening Compliance Communication ↑ Processes ↑ Cost ↓ Provider Centered Effects QOC Knowledge Satisfaction Specialist ↑ Referral Patient Centered Effects Satisfaction with Care Knowledge ↑ Empowerment QOL Adherence Continuity of ↑ Care Hospitalization Depression HbA1c BP (SBP or DBP) Total Cholesterol LDL HDL 18   ↑ ↑ ↑ ↑ ↔ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↓ ↓ ↓ ↑ ↑ ↑ ↑ ↑ ↔ ↓ ↓ ↓ ↓ ↔ ↔ ↓ ↓ ↑ ↑ - Increased, ↓ - Decreased, ↔ - Limited effects, BP – blood pressure, CVD events – cardiovascular disease related events, DBP – diastolic blood pressure, HbA1c – glycosylated hemoglobin level, HDL – high density lipoprotein cholesterol level, LDL – low density lipoprotein cholesterol level, LOE – level of evidence, N – sample size (people), n – sample size (studies/programs), QOC – quality of care, QOL – quality of life, RCT – Randomized Control Trial, SBP – systolic blood pressure, SR – Systematic Review, SR (Q) – Systematic Review (Qualitative study design)   TEAM-BASED CARE IN THE MANAGEMENT OF TYPE 2 DIABET CVD Event ↓ 19   ↓ ↑ - Increased, ↓ - Decreased, ↔ - Limited effects, BP – blood pressure, CVD events – cardiovascular disease related events, DBP – diastolic blood pressure, HbA1c – glycosylated hemoglobin level, HDL – high density lipoprotein cholesterol level, LDL – low density lipoprotein cholesterol level, LOE – level of evidence, N – sample size (people), n – sample size (studies/programs), QOC – quality of care, QOL – quality of life, RCT – Randomized Control Trial, SBP – systolic blood pressure, SR – Systematic Review, SR (Q) – Systematic Review (Qualitative study design)